Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7261
Rank
NZ$1.07 B
Marketcap
NZ$30.64
Share price
0.71%
Change (1 day)
-47.56%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement